nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—HTR2C—Sorafenib—kidney cancer	0.0642	0.128	CbGbCtD
Tramadol—CYP2D6—Temsirolimus—kidney cancer	0.0632	0.126	CbGbCtD
Tramadol—CYP3A4—Everolimus—kidney cancer	0.0595	0.119	CbGbCtD
Tramadol—CYP3A4—Temsirolimus—kidney cancer	0.0402	0.0801	CbGbCtD
Tramadol—CYP2B6—Sorafenib—kidney cancer	0.0399	0.0795	CbGbCtD
Tramadol—CYP2D6—Pazopanib—kidney cancer	0.0332	0.0662	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—kidney cancer	0.0242	0.0482	CbGbCtD
Tramadol—CYP2D6—Erlotinib—kidney cancer	0.0237	0.0472	CbGbCtD
Tramadol—CYP3A4—Pazopanib—kidney cancer	0.0211	0.0421	CbGbCtD
Tramadol—CYP2D6—Sorafenib—kidney cancer	0.0193	0.0384	CbGbCtD
Tramadol—CYP2D6—Vinblastine—kidney cancer	0.019	0.0379	CbGbCtD
Tramadol—CYP3A4—Erlotinib—kidney cancer	0.0151	0.03	CbGbCtD
Tramadol—CYP3A4—Paclitaxel—kidney cancer	0.0138	0.0275	CbGbCtD
Tramadol—CYP3A4—Sorafenib—kidney cancer	0.0122	0.0244	CbGbCtD
Tramadol—CHRM3—ureter—kidney cancer	0.0122	0.437	CbGeAlD
Tramadol—CYP3A4—Vinblastine—kidney cancer	0.0121	0.0241	CbGbCtD
Tramadol—CYP3A4—Vincristine—kidney cancer	0.0119	0.0237	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—kidney cancer	0.0117	0.0233	CbGbCtD
Tramadol—CYP3A4—Sunitinib—kidney cancer	0.00992	0.0198	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—kidney cancer	0.00743	0.0148	CbGbCtD
Tramadol—CYP3A4—urine—kidney cancer	0.00218	0.078	CbGeAlD
Tramadol—CYP2D6—urine—kidney cancer	0.00214	0.0767	CbGeAlD
Tramadol—OPRD1—renal system—kidney cancer	0.00192	0.0687	CbGeAlD
Tramadol—OPRD1—kidney—kidney cancer	0.00185	0.0664	CbGeAlD
Tramadol—CHRM3—renal system—kidney cancer	0.00097	0.0347	CbGeAlD
Tramadol—CHRM3—kidney—kidney cancer	0.000937	0.0336	CbGeAlD
Tramadol—SLC6A2—gonad—kidney cancer	0.000859	0.0307	CbGeAlD
Tramadol—CYP2B6—nephron tubule—kidney cancer	0.000776	0.0278	CbGeAlD
Tramadol—CYP2B6—renal system—kidney cancer	0.000706	0.0253	CbGeAlD
Tramadol—CYP2B6—kidney—kidney cancer	0.000682	0.0244	CbGeAlD
Tramadol—CYP2B6—gonad—kidney cancer	0.000633	0.0227	CbGeAlD
Tramadol—Venlafaxine—ABCB1—kidney cancer	0.000555	0.696	CrCbGaD
Tramadol—CYP3A4—renal system—kidney cancer	0.000533	0.0191	CbGeAlD
Tramadol—CYP2D6—renal system—kidney cancer	0.000524	0.0188	CbGeAlD
Tramadol—CYP3A4—kidney—kidney cancer	0.000515	0.0184	CbGeAlD
Tramadol—CYP2D6—kidney—kidney cancer	0.000507	0.0181	CbGeAlD
Tramadol—Dextromethorphan—ABCB1—kidney cancer	0.000243	0.305	CrCbGaD
Tramadol—Infection—Paclitaxel—kidney cancer	7.37e-05	0.000163	CcSEcCtD
Tramadol—Flatulence—Capecitabine—kidney cancer	7.35e-05	0.000162	CcSEcCtD
Tramadol—Dry skin—Doxorubicin—kidney cancer	7.32e-05	0.000161	CcSEcCtD
Tramadol—Dysgeusia—Capecitabine—kidney cancer	7.3e-05	0.000161	CcSEcCtD
Tramadol—Dizziness—Sunitinib—kidney cancer	7.3e-05	0.000161	CcSEcCtD
Tramadol—Feeling abnormal—Gemcitabine—kidney cancer	7.3e-05	0.000161	CcSEcCtD
Tramadol—Shock—Paclitaxel—kidney cancer	7.3e-05	0.000161	CcSEcCtD
Tramadol—Vomiting—Sorafenib—kidney cancer	7.29e-05	0.000161	CcSEcCtD
Tramadol—Abdominal pain upper—Doxorubicin—kidney cancer	7.29e-05	0.000161	CcSEcCtD
Tramadol—Orthostatic hypotension—Doxorubicin—kidney cancer	7.29e-05	0.000161	CcSEcCtD
Tramadol—Nervous system disorder—Paclitaxel—kidney cancer	7.27e-05	0.000161	CcSEcCtD
Tramadol—Hypokalaemia—Doxorubicin—kidney cancer	7.26e-05	0.00016	CcSEcCtD
Tramadol—Thrombocytopenia—Paclitaxel—kidney cancer	7.26e-05	0.00016	CcSEcCtD
Tramadol—Tachycardia—Paclitaxel—kidney cancer	7.24e-05	0.00016	CcSEcCtD
Tramadol—Rash—Sorafenib—kidney cancer	7.23e-05	0.00016	CcSEcCtD
Tramadol—Dermatitis—Sorafenib—kidney cancer	7.23e-05	0.000159	CcSEcCtD
Tramadol—Back pain—Capecitabine—kidney cancer	7.21e-05	0.000159	CcSEcCtD
Tramadol—Breast disorder—Doxorubicin—kidney cancer	7.21e-05	0.000159	CcSEcCtD
Tramadol—Skin disorder—Paclitaxel—kidney cancer	7.2e-05	0.000159	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	7.19e-05	0.000159	CcSEcCtD
Tramadol—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	7.19e-05	0.000159	CcSEcCtD
Tramadol—Headache—Sorafenib—kidney cancer	7.19e-05	0.000159	CcSEcCtD
Tramadol—Muscle spasms—Capecitabine—kidney cancer	7.17e-05	0.000158	CcSEcCtD
Tramadol—Hyperhidrosis—Paclitaxel—kidney cancer	7.17e-05	0.000158	CcSEcCtD
Tramadol—Diarrhoea—Dactinomycin—kidney cancer	7.15e-05	0.000158	CcSEcCtD
Tramadol—Nasopharyngitis—Doxorubicin—kidney cancer	7.14e-05	0.000158	CcSEcCtD
Tramadol—Anorexia—Paclitaxel—kidney cancer	7.07e-05	0.000156	CcSEcCtD
Tramadol—Gastritis—Doxorubicin—kidney cancer	7.06e-05	0.000156	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Doxorubicin—kidney cancer	7.04e-05	0.000155	CcSEcCtD
Tramadol—Muscular weakness—Doxorubicin—kidney cancer	7.04e-05	0.000155	CcSEcCtD
Tramadol—Vision blurred—Capecitabine—kidney cancer	7.03e-05	0.000155	CcSEcCtD
Tramadol—Vomiting—Sunitinib—kidney cancer	7.02e-05	0.000155	CcSEcCtD
Tramadol—Body temperature increased—Gemcitabine—kidney cancer	7e-05	0.000155	CcSEcCtD
Tramadol—Tremor—Capecitabine—kidney cancer	6.99e-05	0.000154	CcSEcCtD
Tramadol—Rash—Sunitinib—kidney cancer	6.96e-05	0.000154	CcSEcCtD
Tramadol—Dermatitis—Sunitinib—kidney cancer	6.95e-05	0.000153	CcSEcCtD
Tramadol—Abdominal distension—Doxorubicin—kidney cancer	6.94e-05	0.000153	CcSEcCtD
Tramadol—Hypotension—Paclitaxel—kidney cancer	6.93e-05	0.000153	CcSEcCtD
Tramadol—Ill-defined disorder—Capecitabine—kidney cancer	6.92e-05	0.000153	CcSEcCtD
Tramadol—Headache—Sunitinib—kidney cancer	6.92e-05	0.000153	CcSEcCtD
Tramadol—Dysphagia—Doxorubicin—kidney cancer	6.9e-05	0.000152	CcSEcCtD
Tramadol—Asthma—Doxorubicin—kidney cancer	6.9e-05	0.000152	CcSEcCtD
Tramadol—Influenza—Doxorubicin—kidney cancer	6.9e-05	0.000152	CcSEcCtD
Tramadol—Anaemia—Capecitabine—kidney cancer	6.89e-05	0.000152	CcSEcCtD
Tramadol—Hypersensitivity—Vincristine—kidney cancer	6.88e-05	0.000152	CcSEcCtD
Tramadol—Nausea—Sorafenib—kidney cancer	6.81e-05	0.00015	CcSEcCtD
Tramadol—Pancreatitis—Doxorubicin—kidney cancer	6.76e-05	0.000149	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.76e-05	0.000149	CcSEcCtD
Tramadol—Malaise—Capecitabine—kidney cancer	6.72e-05	0.000148	CcSEcCtD
Tramadol—Angina pectoris—Doxorubicin—kidney cancer	6.72e-05	0.000148	CcSEcCtD
Tramadol—Insomnia—Paclitaxel—kidney cancer	6.71e-05	0.000148	CcSEcCtD
Tramadol—Vertigo—Capecitabine—kidney cancer	6.7e-05	0.000148	CcSEcCtD
Tramadol—Asthenia—Vincristine—kidney cancer	6.7e-05	0.000148	CcSEcCtD
Tramadol—Syncope—Capecitabine—kidney cancer	6.69e-05	0.000148	CcSEcCtD
Tramadol—Paraesthesia—Paclitaxel—kidney cancer	6.66e-05	0.000147	CcSEcCtD
Tramadol—Vomiting—Dactinomycin—kidney cancer	6.64e-05	0.000147	CcSEcCtD
Tramadol—Bronchitis—Doxorubicin—kidney cancer	6.63e-05	0.000146	CcSEcCtD
Tramadol—Dyspnoea—Paclitaxel—kidney cancer	6.61e-05	0.000146	CcSEcCtD
Tramadol—Somnolence—Paclitaxel—kidney cancer	6.59e-05	0.000146	CcSEcCtD
Tramadol—Palpitations—Capecitabine—kidney cancer	6.59e-05	0.000145	CcSEcCtD
Tramadol—Rash—Dactinomycin—kidney cancer	6.59e-05	0.000145	CcSEcCtD
Tramadol—Nausea—Sunitinib—kidney cancer	6.56e-05	0.000145	CcSEcCtD
Tramadol—Loss of consciousness—Capecitabine—kidney cancer	6.55e-05	0.000145	CcSEcCtD
Tramadol—Dyspepsia—Paclitaxel—kidney cancer	6.53e-05	0.000144	CcSEcCtD
Tramadol—Cough—Capecitabine—kidney cancer	6.51e-05	0.000144	CcSEcCtD
Tramadol—Dysuria—Doxorubicin—kidney cancer	6.45e-05	0.000142	CcSEcCtD
Tramadol—Decreased appetite—Paclitaxel—kidney cancer	6.45e-05	0.000142	CcSEcCtD
Tramadol—Hypertension—Capecitabine—kidney cancer	6.44e-05	0.000142	CcSEcCtD
Tramadol—Upper respiratory tract infection—Doxorubicin—kidney cancer	6.41e-05	0.000142	CcSEcCtD
Tramadol—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.4e-05	0.000141	CcSEcCtD
Tramadol—Fatigue—Paclitaxel—kidney cancer	6.39e-05	0.000141	CcSEcCtD
Tramadol—Diarrhoea—Vincristine—kidney cancer	6.39e-05	0.000141	CcSEcCtD
Tramadol—Pollakiuria—Doxorubicin—kidney cancer	6.37e-05	0.000141	CcSEcCtD
Tramadol—Asthenia—Gemcitabine—kidney cancer	6.36e-05	0.00014	CcSEcCtD
Tramadol—Arthralgia—Capecitabine—kidney cancer	6.35e-05	0.00014	CcSEcCtD
Tramadol—Chest pain—Capecitabine—kidney cancer	6.35e-05	0.00014	CcSEcCtD
Tramadol—Myalgia—Capecitabine—kidney cancer	6.35e-05	0.00014	CcSEcCtD
Tramadol—Constipation—Paclitaxel—kidney cancer	6.34e-05	0.00014	CcSEcCtD
Tramadol—Pain—Paclitaxel—kidney cancer	6.34e-05	0.00014	CcSEcCtD
Tramadol—Anxiety—Capecitabine—kidney cancer	6.33e-05	0.00014	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.3e-05	0.000139	CcSEcCtD
Tramadol—Photosensitivity reaction—Doxorubicin—kidney cancer	6.3e-05	0.000139	CcSEcCtD
Tramadol—Discomfort—Capecitabine—kidney cancer	6.27e-05	0.000138	CcSEcCtD
Tramadol—Pruritus—Gemcitabine—kidney cancer	6.27e-05	0.000138	CcSEcCtD
Tramadol—Weight decreased—Doxorubicin—kidney cancer	6.24e-05	0.000138	CcSEcCtD
Tramadol—Hyperglycaemia—Doxorubicin—kidney cancer	6.22e-05	0.000137	CcSEcCtD
Tramadol—Dry mouth—Capecitabine—kidney cancer	6.21e-05	0.000137	CcSEcCtD
Tramadol—Nausea—Dactinomycin—kidney cancer	6.21e-05	0.000137	CcSEcCtD
Tramadol—Pneumonia—Doxorubicin—kidney cancer	6.19e-05	0.000137	CcSEcCtD
Tramadol—Dizziness—Vincristine—kidney cancer	6.17e-05	0.000136	CcSEcCtD
Tramadol—Infestation NOS—Doxorubicin—kidney cancer	6.15e-05	0.000136	CcSEcCtD
Tramadol—Infestation—Doxorubicin—kidney cancer	6.15e-05	0.000136	CcSEcCtD
Tramadol—Confusional state—Capecitabine—kidney cancer	6.14e-05	0.000135	CcSEcCtD
Tramadol—Feeling abnormal—Paclitaxel—kidney cancer	6.11e-05	0.000135	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	6.1e-05	0.000135	CcSEcCtD
Tramadol—Gastrointestinal pain—Paclitaxel—kidney cancer	6.06e-05	0.000134	CcSEcCtD
Tramadol—Diarrhoea—Gemcitabine—kidney cancer	6.06e-05	0.000134	CcSEcCtD
Tramadol—Renal failure—Doxorubicin—kidney cancer	6.05e-05	0.000133	CcSEcCtD
Tramadol—Infection—Capecitabine—kidney cancer	6.05e-05	0.000133	CcSEcCtD
Tramadol—Stomatitis—Doxorubicin—kidney cancer	6e-05	0.000132	CcSEcCtD
Tramadol—Shock—Capecitabine—kidney cancer	5.99e-05	0.000132	CcSEcCtD
Tramadol—Conjunctivitis—Doxorubicin—kidney cancer	5.98e-05	0.000132	CcSEcCtD
Tramadol—Urinary tract infection—Doxorubicin—kidney cancer	5.98e-05	0.000132	CcSEcCtD
Tramadol—Nervous system disorder—Capecitabine—kidney cancer	5.97e-05	0.000132	CcSEcCtD
Tramadol—Thrombocytopenia—Capecitabine—kidney cancer	5.96e-05	0.000132	CcSEcCtD
Tramadol—Tachycardia—Capecitabine—kidney cancer	5.94e-05	0.000131	CcSEcCtD
Tramadol—Vomiting—Vincristine—kidney cancer	5.94e-05	0.000131	CcSEcCtD
Tramadol—Skin disorder—Capecitabine—kidney cancer	5.91e-05	0.00013	CcSEcCtD
Tramadol—Sweating—Doxorubicin—kidney cancer	5.9e-05	0.00013	CcSEcCtD
Tramadol—Urticaria—Paclitaxel—kidney cancer	5.89e-05	0.00013	CcSEcCtD
Tramadol—Rash—Vincristine—kidney cancer	5.89e-05	0.00013	CcSEcCtD
Tramadol—Hyperhidrosis—Capecitabine—kidney cancer	5.88e-05	0.00013	CcSEcCtD
Tramadol—Dermatitis—Vincristine—kidney cancer	5.88e-05	0.00013	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—kidney cancer	5.86e-05	0.000129	CcSEcCtD
Tramadol—Abdominal pain—Paclitaxel—kidney cancer	5.86e-05	0.000129	CcSEcCtD
Tramadol—Body temperature increased—Paclitaxel—kidney cancer	5.86e-05	0.000129	CcSEcCtD
Tramadol—Headache—Vincristine—kidney cancer	5.85e-05	0.000129	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—kidney cancer	5.82e-05	0.000128	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—kidney cancer	5.8e-05	0.000128	CcSEcCtD
Tramadol—Anorexia—Capecitabine—kidney cancer	5.8e-05	0.000128	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—kidney cancer	5.77e-05	0.000127	CcSEcCtD
Tramadol—Hypotension—Capecitabine—kidney cancer	5.69e-05	0.000126	CcSEcCtD
Tramadol—Vomiting—Gemcitabine—kidney cancer	5.63e-05	0.000124	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—kidney cancer	5.62e-05	0.000124	CcSEcCtD
Tramadol—Rash—Gemcitabine—kidney cancer	5.58e-05	0.000123	CcSEcCtD
Tramadol—Dermatitis—Gemcitabine—kidney cancer	5.58e-05	0.000123	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—kidney cancer	5.55e-05	0.000122	CcSEcCtD
Tramadol—Headache—Gemcitabine—kidney cancer	5.55e-05	0.000122	CcSEcCtD
Tramadol—Nausea—Vincristine—kidney cancer	5.55e-05	0.000122	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.54e-05	0.000122	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—kidney cancer	5.54e-05	0.000122	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—kidney cancer	5.52e-05	0.000122	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—kidney cancer	5.52e-05	0.000122	CcSEcCtD
Tramadol—Insomnia—Capecitabine—kidney cancer	5.5e-05	0.000121	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—kidney cancer	5.49e-05	0.000121	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—kidney cancer	5.48e-05	0.000121	CcSEcCtD
Tramadol—Paraesthesia—Capecitabine—kidney cancer	5.46e-05	0.000121	CcSEcCtD
Tramadol—Hypersensitivity—Paclitaxel—kidney cancer	5.46e-05	0.000121	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—kidney cancer	5.45e-05	0.00012	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—kidney cancer	5.44e-05	0.00012	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—kidney cancer	5.43e-05	0.00012	CcSEcCtD
Tramadol—Dyspnoea—Capecitabine—kidney cancer	5.43e-05	0.00012	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—kidney cancer	5.41e-05	0.000119	CcSEcCtD
Tramadol—Dyspepsia—Capecitabine—kidney cancer	5.36e-05	0.000118	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—kidney cancer	5.32e-05	0.000117	CcSEcCtD
Tramadol—Asthenia—Paclitaxel—kidney cancer	5.32e-05	0.000117	CcSEcCtD
Tramadol—Decreased appetite—Capecitabine—kidney cancer	5.29e-05	0.000117	CcSEcCtD
Tramadol—Nausea—Gemcitabine—kidney cancer	5.26e-05	0.000116	CcSEcCtD
Tramadol—Gastrointestinal disorder—Capecitabine—kidney cancer	5.25e-05	0.000116	CcSEcCtD
Tramadol—Fatigue—Capecitabine—kidney cancer	5.25e-05	0.000116	CcSEcCtD
Tramadol—Pruritus—Paclitaxel—kidney cancer	5.25e-05	0.000116	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—kidney cancer	5.22e-05	0.000115	CcSEcCtD
Tramadol—Pain—Capecitabine—kidney cancer	5.2e-05	0.000115	CcSEcCtD
Tramadol—Constipation—Capecitabine—kidney cancer	5.2e-05	0.000115	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—kidney cancer	5.16e-05	0.000114	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—kidney cancer	5.15e-05	0.000114	CcSEcCtD
Tramadol—Flushing—Doxorubicin—kidney cancer	5.12e-05	0.000113	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—kidney cancer	5.12e-05	0.000113	CcSEcCtD
Tramadol—Diarrhoea—Paclitaxel—kidney cancer	5.07e-05	0.000112	CcSEcCtD
Tramadol—Feeling abnormal—Capecitabine—kidney cancer	5.02e-05	0.000111	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—kidney cancer	5.01e-05	0.000111	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—kidney cancer	4.99e-05	0.00011	CcSEcCtD
Tramadol—Gastrointestinal pain—Capecitabine—kidney cancer	4.98e-05	0.00011	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—kidney cancer	4.98e-05	0.00011	CcSEcCtD
Tramadol—Chills—Doxorubicin—kidney cancer	4.95e-05	0.000109	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—kidney cancer	4.93e-05	0.000109	CcSEcCtD
Tramadol—Dizziness—Paclitaxel—kidney cancer	4.9e-05	0.000108	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—kidney cancer	4.84e-05	0.000107	CcSEcCtD
Tramadol—Urticaria—Capecitabine—kidney cancer	4.83e-05	0.000107	CcSEcCtD
Tramadol—Abdominal pain—Capecitabine—kidney cancer	4.81e-05	0.000106	CcSEcCtD
Tramadol—Body temperature increased—Capecitabine—kidney cancer	4.81e-05	0.000106	CcSEcCtD
Tramadol—Erythema—Doxorubicin—kidney cancer	4.81e-05	0.000106	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—kidney cancer	4.81e-05	0.000106	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—kidney cancer	4.74e-05	0.000105	CcSEcCtD
Tramadol—Tension—Doxorubicin—kidney cancer	4.72e-05	0.000104	CcSEcCtD
Tramadol—Vomiting—Paclitaxel—kidney cancer	4.72e-05	0.000104	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—kidney cancer	4.71e-05	0.000104	CcSEcCtD
Tramadol—Rash—Paclitaxel—kidney cancer	4.68e-05	0.000103	CcSEcCtD
Tramadol—Dermatitis—Paclitaxel—kidney cancer	4.67e-05	0.000103	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—kidney cancer	4.67e-05	0.000103	CcSEcCtD
Tramadol—Back pain—Doxorubicin—kidney cancer	4.65e-05	0.000103	CcSEcCtD
Tramadol—Headache—Paclitaxel—kidney cancer	4.65e-05	0.000103	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—kidney cancer	4.62e-05	0.000102	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—kidney cancer	4.53e-05	0.0001	CcSEcCtD
Tramadol—Hypersensitivity—Capecitabine—kidney cancer	4.48e-05	9.9e-05	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—kidney cancer	4.46e-05	9.84e-05	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—kidney cancer	4.44e-05	9.81e-05	CcSEcCtD
Tramadol—Agitation—Doxorubicin—kidney cancer	4.42e-05	9.75e-05	CcSEcCtD
Tramadol—Nausea—Paclitaxel—kidney cancer	4.41e-05	9.72e-05	CcSEcCtD
Tramadol—Asthenia—Capecitabine—kidney cancer	4.37e-05	9.64e-05	CcSEcCtD
Tramadol—Malaise—Doxorubicin—kidney cancer	4.33e-05	9.57e-05	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—kidney cancer	4.32e-05	9.53e-05	CcSEcCtD
Tramadol—Syncope—Doxorubicin—kidney cancer	4.31e-05	9.51e-05	CcSEcCtD
Tramadol—Pruritus—Capecitabine—kidney cancer	4.31e-05	9.5e-05	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—kidney cancer	4.25e-05	9.38e-05	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—kidney cancer	4.22e-05	9.32e-05	CcSEcCtD
Tramadol—Cough—Doxorubicin—kidney cancer	4.19e-05	9.26e-05	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—kidney cancer	4.16e-05	9.19e-05	CcSEcCtD
Tramadol—Diarrhoea—Capecitabine—kidney cancer	4.16e-05	9.19e-05	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—kidney cancer	4.15e-05	9.16e-05	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—kidney cancer	4.09e-05	9.03e-05	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—kidney cancer	4.09e-05	9.03e-05	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—kidney cancer	4.09e-05	9.03e-05	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—kidney cancer	4.08e-05	9e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.06e-05	8.97e-05	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—kidney cancer	4.04e-05	8.92e-05	CcSEcCtD
Tramadol—Dizziness—Capecitabine—kidney cancer	4.02e-05	8.88e-05	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—kidney cancer	4e-05	8.83e-05	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—kidney cancer	3.96e-05	8.73e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—kidney cancer	3.92e-05	8.66e-05	CcSEcCtD
Tramadol—Infection—Doxorubicin—kidney cancer	3.9e-05	8.6e-05	CcSEcCtD
Tramadol—Vomiting—Capecitabine—kidney cancer	3.87e-05	8.54e-05	CcSEcCtD
Tramadol—Shock—Doxorubicin—kidney cancer	3.86e-05	8.52e-05	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—kidney cancer	3.85e-05	8.49e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—kidney cancer	3.84e-05	8.48e-05	CcSEcCtD
Tramadol—Rash—Capecitabine—kidney cancer	3.84e-05	8.47e-05	CcSEcCtD
Tramadol—Dermatitis—Capecitabine—kidney cancer	3.83e-05	8.46e-05	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—kidney cancer	3.83e-05	8.45e-05	CcSEcCtD
Tramadol—Headache—Capecitabine—kidney cancer	3.81e-05	8.41e-05	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—kidney cancer	3.81e-05	8.41e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—kidney cancer	3.79e-05	8.37e-05	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—kidney cancer	3.74e-05	8.25e-05	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—kidney cancer	3.67e-05	8.09e-05	CcSEcCtD
Tramadol—Nausea—Capecitabine—kidney cancer	3.61e-05	7.98e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.57e-05	7.89e-05	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—kidney cancer	3.55e-05	7.83e-05	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—kidney cancer	3.52e-05	7.77e-05	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—kidney cancer	3.5e-05	7.72e-05	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—kidney cancer	3.49e-05	7.7e-05	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—kidney cancer	3.45e-05	7.62e-05	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—kidney cancer	3.41e-05	7.53e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.39e-05	7.47e-05	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—kidney cancer	3.38e-05	7.46e-05	CcSEcCtD
Tramadol—Pain—Doxorubicin—kidney cancer	3.35e-05	7.4e-05	CcSEcCtD
Tramadol—Constipation—Doxorubicin—kidney cancer	3.35e-05	7.4e-05	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—kidney cancer	3.23e-05	7.13e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—kidney cancer	3.21e-05	7.08e-05	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—kidney cancer	3.12e-05	6.88e-05	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—kidney cancer	3.1e-05	6.84e-05	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—kidney cancer	3.1e-05	6.84e-05	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—kidney cancer	2.89e-05	6.38e-05	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—kidney cancer	2.81e-05	6.21e-05	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—kidney cancer	2.78e-05	6.13e-05	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—kidney cancer	2.68e-05	5.92e-05	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—kidney cancer	2.59e-05	5.73e-05	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—kidney cancer	2.49e-05	5.5e-05	CcSEcCtD
Tramadol—Rash—Doxorubicin—kidney cancer	2.47e-05	5.46e-05	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—kidney cancer	2.47e-05	5.45e-05	CcSEcCtD
Tramadol—Headache—Doxorubicin—kidney cancer	2.46e-05	5.42e-05	CcSEcCtD
Tramadol—Nausea—Doxorubicin—kidney cancer	2.33e-05	5.14e-05	CcSEcCtD
Tramadol—CHRM3—Metabolism—SLC2A1—kidney cancer	6.87e-06	0.000411	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL2—kidney cancer	6.86e-06	0.000411	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CA9—kidney cancer	6.85e-06	0.00041	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EIF4EBP1—kidney cancer	6.83e-06	0.000409	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HSPB1—kidney cancer	6.83e-06	0.000409	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HIF1A—kidney cancer	6.77e-06	0.000405	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TSC2—kidney cancer	6.75e-06	0.000404	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—POMC—kidney cancer	6.73e-06	0.000403	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SCARB1—kidney cancer	6.73e-06	0.000403	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS1—kidney cancer	6.66e-06	0.000399	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JUNB—kidney cancer	6.62e-06	0.000396	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PAK1—kidney cancer	6.62e-06	0.000396	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PSMD7—kidney cancer	6.53e-06	0.000391	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KDR—kidney cancer	6.47e-06	0.000388	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—FH—kidney cancer	6.46e-06	0.000387	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APRT—kidney cancer	6.46e-06	0.000387	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ANXA1—kidney cancer	6.35e-06	0.00038	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSC1—kidney cancer	6.35e-06	0.00038	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PSMD7—kidney cancer	6.35e-06	0.00038	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF2—kidney cancer	6.3e-06	0.000377	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	6.27e-06	0.000376	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL2—kidney cancer	6.23e-06	0.000373	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—BCHE—kidney cancer	6.19e-06	0.000371	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FLT1—kidney cancer	6.15e-06	0.000368	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SLC5A5—kidney cancer	6.12e-06	0.000366	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—POMC—kidney cancer	6.11e-06	0.000366	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1R—kidney cancer	6.09e-06	0.000365	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPC3—kidney cancer	6.08e-06	0.000364	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KIT—kidney cancer	5.96e-06	0.000357	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—APC—kidney cancer	5.96e-06	0.000357	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HIF1A—kidney cancer	5.93e-06	0.000355	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TSC2—kidney cancer	5.92e-06	0.000355	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CA2—kidney cancer	5.91e-06	0.000354	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SLC2A1—kidney cancer	5.91e-06	0.000354	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—RAF1—kidney cancer	5.87e-06	0.000352	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CRABP1—kidney cancer	5.83e-06	0.000349	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—POMC—kidney cancer	5.8e-06	0.000347	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL2—kidney cancer	5.8e-06	0.000347	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALAD—kidney cancer	5.76e-06	0.000345	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTP1—kidney cancer	5.73e-06	0.000343	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—MAPK3—kidney cancer	5.71e-06	0.000342	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JUNB—kidney cancer	5.7e-06	0.000341	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PAK1—kidney cancer	5.7e-06	0.000341	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—POMC—kidney cancer	5.68e-06	0.00034	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KDR—kidney cancer	5.68e-06	0.00034	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.62e-06	0.000337	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—BRAF—kidney cancer	5.6e-06	0.000336	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.5e-06	0.000329	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—MAPK1—kidney cancer	5.43e-06	0.000325	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ABCB1—kidney cancer	5.42e-06	0.000325	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ITPR2—kidney cancer	5.42e-06	0.000324	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF2—kidney cancer	5.41e-06	0.000324	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN2B—kidney cancer	5.39e-06	0.000323	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.27e-06	0.000316	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PGK1—kidney cancer	5.27e-06	0.000316	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—POMC—kidney cancer	5.26e-06	0.000315	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL2—kidney cancer	5.26e-06	0.000315	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTM1—kidney cancer	5.26e-06	0.000315	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1R—kidney cancer	5.23e-06	0.000313	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KIT—kidney cancer	5.23e-06	0.000313	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—APC—kidney cancer	5.23e-06	0.000313	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—PIK3CA—kidney cancer	5.19e-06	0.000311	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LDHB—kidney cancer	5.17e-06	0.000309	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—KRAS—kidney cancer	5.13e-06	0.000307	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—RAF1—kidney cancer	5.04e-06	0.000302	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HIF1A—kidney cancer	5.02e-06	0.0003	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	5.01e-06	0.0003	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TSC2—kidney cancer	5e-06	0.0003	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP1A1—kidney cancer	4.99e-06	0.000299	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL2—kidney cancer	4.98e-06	0.000298	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—POMC—kidney cancer	4.98e-06	0.000298	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTT1—kidney cancer	4.94e-06	0.000296	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ACHE—kidney cancer	4.94e-06	0.000296	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTP1—kidney cancer	4.93e-06	0.000295	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—BRAF—kidney cancer	4.91e-06	0.000294	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KDR—kidney cancer	4.8e-06	0.000287	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	4.76e-06	0.000285	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PIK3CA—kidney cancer	4.72e-06	0.000282	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RAF1—kidney cancer	4.68e-06	0.00028	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SCARB1—kidney cancer	4.68e-06	0.00028	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ABCB1—kidney cancer	4.66e-06	0.000279	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF2—kidney cancer	4.66e-06	0.000279	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RELA—kidney cancer	4.66e-06	0.000279	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	4.64e-06	0.000278	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ERBB2—kidney cancer	4.63e-06	0.000277	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS1—kidney cancer	4.63e-06	0.000277	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MTOR—kidney cancer	4.57e-06	0.000274	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	4.55e-06	0.000273	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PSMD7—kidney cancer	4.54e-06	0.000272	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTM1—kidney cancer	4.53e-06	0.000271	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2—kidney cancer	4.52e-06	0.000271	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1R—kidney cancer	4.5e-06	0.00027	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—KRAS—kidney cancer	4.5e-06	0.00027	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CA9—kidney cancer	4.48e-06	0.000268	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APC—kidney cancer	4.42e-06	0.000265	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KIT—kidney cancer	4.42e-06	0.000265	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RAF1—kidney cancer	4.34e-06	0.00026	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HIF1A—kidney cancer	4.31e-06	0.000258	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—BCHE—kidney cancer	4.3e-06	0.000258	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TSC2—kidney cancer	4.3e-06	0.000257	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP1A1—kidney cancer	4.29e-06	0.000257	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CDKN1B—kidney cancer	4.29e-06	0.000257	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2—kidney cancer	4.29e-06	0.000257	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.25e-06	0.000255	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	4.23e-06	0.000253	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—POMC—kidney cancer	4.21e-06	0.000252	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2—kidney cancer	4.2e-06	0.000251	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BRAF—kidney cancer	4.15e-06	0.000249	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	4.13e-06	0.000248	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KDR—kidney cancer	4.12e-06	0.000247	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.11e-06	0.000246	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RAF1—kidney cancer	4.1e-06	0.000246	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCND1—kidney cancer	4.09e-06	0.000245	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RELA—kidney cancer	4.09e-06	0.000245	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—JUN—kidney cancer	4.08e-06	0.000244	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ERBB2—kidney cancer	4.06e-06	0.000243	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CTNNB1—kidney cancer	4.05e-06	0.000243	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	4.03e-06	0.000241	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MTOR—kidney cancer	4.01e-06	0.00024	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTEN—kidney cancer	3.95e-06	0.000236	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2—kidney cancer	3.89e-06	0.000233	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	3.85e-06	0.00023	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CRABP1—kidney cancer	3.81e-06	0.000228	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—kidney cancer	3.8e-06	0.000228	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APC—kidney cancer	3.79e-06	0.000227	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KIT—kidney cancer	3.79e-06	0.000227	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	3.76e-06	0.000225	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—POMC—kidney cancer	3.72e-06	0.000223	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—kidney cancer	3.71e-06	0.000222	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSC2—kidney cancer	3.7e-06	0.000222	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—kidney cancer	3.68e-06	0.00022	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—MAPK3—kidney cancer	3.63e-06	0.000218	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—POMC—kidney cancer	3.61e-06	0.000216	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—kidney cancer	3.59e-06	0.000215	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—JUN—kidney cancer	3.58e-06	0.000214	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—kidney cancer	3.57e-06	0.000214	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—kidney cancer	3.57e-06	0.000214	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	3.55e-06	0.000213	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—kidney cancer	3.55e-06	0.000212	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ITPR2—kidney cancer	3.54e-06	0.000212	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	3.49e-06	0.000209	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAF1—kidney cancer	3.47e-06	0.000208	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—kidney cancer	3.46e-06	0.000207	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—MAPK1—kidney cancer	3.46e-06	0.000207	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RELA—kidney cancer	3.45e-06	0.000207	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—kidney cancer	3.43e-06	0.000205	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—kidney cancer	3.42e-06	0.000205	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MTOR—kidney cancer	3.39e-06	0.000203	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK3—kidney cancer	3.37e-06	0.000202	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—kidney cancer	3.3e-06	0.000198	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—kidney cancer	3.28e-06	0.000196	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APC—kidney cancer	3.27e-06	0.000196	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KIT—kidney cancer	3.27e-06	0.000196	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—kidney cancer	3.27e-06	0.000196	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCB1—kidney cancer	3.24e-06	0.000194	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ACHE—kidney cancer	3.23e-06	0.000193	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTT1—kidney cancer	3.23e-06	0.000193	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK1—kidney cancer	3.21e-06	0.000192	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—POMC—kidney cancer	3.2e-06	0.000192	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	3.18e-06	0.00019	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—kidney cancer	3.15e-06	0.000188	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	3.13e-06	0.000187	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—kidney cancer	3.13e-06	0.000187	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—POMC—kidney cancer	3.11e-06	0.000186	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—kidney cancer	3.11e-06	0.000186	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—kidney cancer	3.07e-06	0.000184	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SCARB1—kidney cancer	3.06e-06	0.000183	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—kidney cancer	3.03e-06	0.000182	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—kidney cancer	3.03e-06	0.000182	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS1—kidney cancer	3.03e-06	0.000181	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JUN—kidney cancer	3.03e-06	0.000181	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	3e-06	0.00018	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	3e-06	0.00018	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.98e-06	0.000179	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAF1—kidney cancer	2.98e-06	0.000178	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	2.98e-06	0.000178	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PSMD7—kidney cancer	2.97e-06	0.000178	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—kidney cancer	2.97e-06	0.000178	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RELA—kidney cancer	2.97e-06	0.000178	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK3—kidney cancer	2.96e-06	0.000177	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—kidney cancer	2.95e-06	0.000176	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—kidney cancer	2.93e-06	0.000175	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MTOR—kidney cancer	2.91e-06	0.000174	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—kidney cancer	2.88e-06	0.000172	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	2.84e-06	0.00017	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK1—kidney cancer	2.81e-06	0.000169	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—BCHE—kidney cancer	2.81e-06	0.000168	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—kidney cancer	2.81e-06	0.000168	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—kidney cancer	2.79e-06	0.000167	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.78e-06	0.000166	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	2.73e-06	0.000163	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—kidney cancer	2.69e-06	0.000161	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.68e-06	0.000161	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—kidney cancer	2.67e-06	0.00016	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—kidney cancer	2.66e-06	0.000159	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—kidney cancer	2.64e-06	0.000158	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—kidney cancer	2.6e-06	0.000156	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JUN—kidney cancer	2.6e-06	0.000156	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—kidney cancer	2.59e-06	0.000155	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	2.58e-06	0.000155	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.58e-06	0.000154	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAF1—kidney cancer	2.56e-06	0.000154	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RELA—kidney cancer	2.55e-06	0.000153	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—kidney cancer	2.55e-06	0.000153	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—kidney cancer	2.54e-06	0.000152	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.51e-06	0.00015	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MTOR—kidney cancer	2.5e-06	0.00015	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK3—kidney cancer	2.5e-06	0.00015	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	2.44e-06	0.000146	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—kidney cancer	2.43e-06	0.000146	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK1—kidney cancer	2.38e-06	0.000142	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—kidney cancer	2.36e-06	0.000142	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	2.35e-06	0.000141	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—kidney cancer	2.3e-06	0.000138	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.27e-06	0.000136	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—kidney cancer	2.25e-06	0.000135	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—kidney cancer	2.24e-06	0.000134	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—kidney cancer	2.24e-06	0.000134	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JUN—kidney cancer	2.24e-06	0.000134	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—kidney cancer	2.23e-06	0.000133	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—POMC—kidney cancer	2.22e-06	0.000133	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	2.22e-06	0.000133	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—kidney cancer	2.16e-06	0.00013	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK3—kidney cancer	2.15e-06	0.000129	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCB1—kidney cancer	2.12e-06	0.000127	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—kidney cancer	2.09e-06	0.000125	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	2.06e-06	0.000124	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—kidney cancer	2.06e-06	0.000123	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK1—kidney cancer	2.04e-06	0.000122	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—kidney cancer	2e-06	0.00012	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—kidney cancer	1.95e-06	0.000117	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.95e-06	0.000117	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—kidney cancer	1.93e-06	0.000116	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK3—kidney cancer	1.85e-06	0.000111	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—kidney cancer	1.83e-06	0.000109	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—kidney cancer	1.8e-06	0.000108	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—kidney cancer	1.77e-06	0.000106	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.77e-06	0.000106	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.76e-06	0.000105	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—kidney cancer	1.71e-06	0.000103	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.66e-06	9.95e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.57e-06	9.4e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—kidney cancer	1.55e-06	9.26e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.53e-06	9.14e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—kidney cancer	1.48e-06	8.84e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—POMC—kidney cancer	1.45e-06	8.71e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—kidney cancer	1.16e-06	6.95e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.09e-06	6.54e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—kidney cancer	1.01e-06	6.06e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.13e-07	4.27e-05	CbGpPWpGaD
